A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
GlaxoSmithKline
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
Shanghai JMT-Bio Inc.
Puma Biotechnology, Inc.
GlaxoSmithKline
Qilu Pharmaceutical Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital
NRG Oncology
RemeGen Co., Ltd.
University of Pittsburgh
Merck Sharp & Dohme LLC
Intergroupe Francophone de Cancerologie Thoracique
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Gruppo Oncologico Italiano di Ricerca Clinica